Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Aug 21, 2014; 20(31): 10802-10812
Published online Aug 21, 2014. doi: 10.3748/wjg.v20.i31.10802
Published online Aug 21, 2014. doi: 10.3748/wjg.v20.i31.10802
Prognostic factors related with survival in patients with pancreatic adenocarcinoma
Ahmet Bilici, Department of Medical Oncology, Medical Faculty, Istanbul Medipol University, 34214 Bagcilar, Istanbul, Turkey
Author contributions: Bilici A designed and wrote the highlight topic.
Correspondence to: Ahmet Bilici, MD, Department of Medical Oncology, Medical Faculty, Istanbul Medipol University, TEM Avrupa Otoyolu Goztepe Cikisi No: 1, 34214 Bagcilar, Istanbul, Turkey. ahmetknower@yahoo.com
Telephone: +90-532-5280486 Fax:+90-216-4422947
Received: October 26, 2013
Revised: January 27, 2014
Accepted: April 8, 2014
Published online: August 21, 2014
Processing time: 298 Days and 14.7 Hours
Revised: January 27, 2014
Accepted: April 8, 2014
Published online: August 21, 2014
Processing time: 298 Days and 14.7 Hours
Core Tip
Core tip: The overall prognosis associated with pancreatic cancer has not improved over the last 20 years, even if new diagnostic and therapeutic strategies have emerged. Thus, investigations on predictive factors in pancreatic cancer are needed because these factors should have predictive value in relation to longer survival after surgery than after palliative treatment.Prognostic factors are important and a correct definition of poor prognostic factors may help to guide more aggressive adjuvant or aggressive treatment protocols in patients with pancreatic cancer.